96 results
DEFM14A
GHSI
Guardion Health Sciences Inc
8 Apr 24
Proxy related to merger
4:28pm
potential risks:
Continuing a Growth Strategy. The Board considered, among other things, the volatility of our earnings, our limited cash resources … , in whether to continue a growth strategy versus a sales process for the Company, in whole or in part. The Board determined that if it could secure a high
PREM14A
GHSI
Guardion Health Sciences Inc
20 Mar 24
Preliminary proxy related to merger
8:15pm
Strategy. The Board considered, among other things, the volatility of our earnings, our limited cash resources for new investment, our low market … , larger revenues and greater resources than our own, and the high cost of being a U.S. public registrant, in whether to continue a growth strategy
425
GHSI
Guardion Health Sciences Inc
31 Jan 24
Business combination disclosure
5:21pm
by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “target,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should
8-K
h75nm42
31 Jan 24
Entry into a Material Definitive Agreement
5:18pm
8-K
EX-99.1
p6pry8685
13 Nov 23
Guardion Health Sciences Announces Financial Results
4:15pm
8-K
EX-99.1
k3j49 p34zfk
14 Aug 23
Results of Operations and Financial Condition
4:48pm
8-K
EX-99.1
chupjkc8og
30 May 23
Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall
5:29pm
8-K
EX-99.1
77hfy6c09nz iq
16 May 23
Guardion Health Sciences Announces Financial Results
6:07am
8-K
EX-99.1
fehtc3
20 Apr 23
Results of Operations and Financial Condition
4:15pm
8-K
EX-99.1
ghbw9o4jkiqhq59dd3t5
14 Nov 22
Guardion Health Sciences Announces Financial Results
5:16pm
8-K
EX-99.1
0gtb1 4w0z
12 Aug 22
Guardion Health Sciences Announces Financial Results
4:15pm